Switch to:
GuruFocus articles
Headlines from internet
Oct-06-17$38.17 (+2.14%)
12:37PMUpdates Pcsk9 Inhibitor Legal Pipeline Scene Seekingalpha
Sep-28-17$36.61 (-0.38%)
03:24AMMedicines Company Watchlist Recent Fda Nod Seekingalpha
Sep-19-17$33.85 (-2.2%)
11:20AMAlnylam Back Foot Heading Major Event Seekingalpha
Sep-01-17$37.83 (+3.11%)
11:49AMBiotech Forum Daily Digest: Biotech Surges Ahead Seekingalpha
Aug-31-17$36.69 (+0.71%)
08:52AMDynavax: Date With Destiny Seekingalpha
Jul-31-17$38.45 (+0.1%)
03:05PMThe Medicines Company Stock Attractively Priced Ahead Of FDA Decision Seekingalpha
Jul-25-17$38.73 (-1.25%)
02:23PMBiotech Forum Daily Digest: Sector Meanders In Front Of Earnings Seekingalpha
Jul-21-17$39.47 (+1%)
10:18AMSirukumab's Panel And U.S. Decision For Medicines Company Seekingalpha
Jul-10-17$37.93 (-1.04%)
04:52PMAlnylam And Sanofi Produce Monster Alternative In Hemophilia Market Seekingalpha
May-09-17$46.6 (-0.04%)
04:54PMThe Medicines Company Gets The Go-Ahead On Novel Cardiovascular Drug Seekingalpha
May-01-17$49.44 (+0.24%)
03:54PMAlnylam Teams Up With The Medicines Company To Upset PCSK9 Antibody Market Seekingalpha
Apr-28-17$49.32 (+1.52%)
03:50PMSnippets Roundup: Sanofi Diabetes Disappointment, And Amgen Pullback Signals CGRP Caution Seekingalpha
Apr-12-17$54 (-1.28%)
10:30AMMotif Bio: Way Too Risky Seekingalpha
Apr-10-17$52.84 (+1.87%)
05:26PMPatisiran, Chronicle Of A Death Foretold Seekingalpha


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK